Korro Bio, Inc. (KRRO) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Cambridge, MA, 美国. 现任CEO为 Ram Aiyar.
KRRO 拥有 IPO日期为 2019-10-03, 112 名全职员工, 在 NASDAQ Capital Marke, 市值为 $128.59M.
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
